Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis.

MLA

Akiyama, Mitsuhiro, et al. “Disease-Specific Expansion of CD29+IL-17RA+ T Effector Cells Possessing Multiple Signalling Pathways in Spondyloarthritis.” Rheumatology, vol. 62, no. 3, Mar. 2023, pp. 1296–305. EBSCOhost, https://doi.org/10.1093/rheumatology/keac391.

APA

Akiyama, M., Yoshimoto, K., Ishigaki, S., Suzuki, K., Takeuchi, T., & Kaneko, Y. (2023). Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis. Rheumatology, 62(3), 1296–1305. https://doi.org/10.1093/rheumatology/keac391

Chicago

Akiyama, Mitsuhiro, Keiko Yoshimoto, Sho Ishigaki, Katsuya Suzuki, Tsutomu Takeuchi, and Yuko Kaneko. 2023. “Disease-Specific Expansion of CD29+IL-17RA+ T Effector Cells Possessing Multiple Signalling Pathways in Spondyloarthritis.” Rheumatology 62 (3): 1296–1305. doi:10.1093/rheumatology/keac391.